Vivistim Registry for Paired VNS Therapy (GRASP)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorMicroTransponder Inc.

About this trial

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.

Eligibility criteria

Qualifiers

Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke

Disqualifiers

Not eligible for surgery

Trial design

Treatments tested in this trial

  • Vivistim System

Treatment groups

No treatment groups listed

Locations

15
Florida
Advent Health Orlando32803, Orlando United States
Illinois
Alexian Brothers Health System60007, Elk Grove Village United States
Endeavor Health60201, Evanston United States
Kansas
University of Kansas Medical Center66160, Kansas City United States

Sponsors and collaborators

MicroTransponder Inc.

Lead sponsor